41 – 50 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
(
- Contribution to journal › Article
-
Mark
Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register
(
- Contribution to journal › Article
- 2022
-
Mark
Predictors and early biomarkers in Giant Cell Arteritis
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Pain in rheumatoid arthritis : a seven-year follow-up study of pain distribution and factors associated with transition from and to chronic widespread pain
(
- Contribution to journal › Article
-
Mark
Serum IFNα2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome
(
- Contribution to journal › Article
-
Mark
Comment on : Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: Results from a national register-based cohort study. Reply
(
- Contribution to journal › Letter
-
Mark
Complement C4 copy number variation is linked to SSA/Ro and SSB/La autoantibodies in systemic inflammatory autoimmune diseases
(
- Contribution to journal › Article
-
Mark
Reumatiska sjukdomar och osteoporos
2022) p.425-476(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Is increased size at birth associated with longevity on the population level? – A historical and comparative analysis of regions in Sweden
(
- Contribution to journal › Article
-
Mark
Pathogenesis of giant cell arteritis with focus on cellular populations
(
- Contribution to journal › Scientific review